Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
NPJ Genomic Medicine
|
February 19, 2022
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data
Javier Lanillos, Marta Carcajona, Paolo Maietta, et al.
European Urology
|
June 10, 2022
Interrogating the Significance of PARP1 Expression and PBRM1 Mutation as Biomarkers for Predicting the Response to Atezolizumab plus Bevacizumab or to Sunitinib in Patients with Clear Cell Renal Cell Carcinoma
Javier Lanillos, María Santos, Carlos Valdivia, et al.
Orphanet Journal of Rare Diseases
|
March 1, 2022
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
Laura Pena-Couso, María Ercibengoa, Fátima Mercadillo, et al.
Journal of Clinical Medicine
|
July 8, 2020
A Novel Approach for the Identification of Pharmacogenetic Variants in <i>MT-RNR1</i> through Next-Generation Sequencing Off-Target Data
Javier Lanillos, María Santos, Marta Carcajona, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 14, 2021
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma
María Santos, Javier Lanillos, Juan María Roldan-Romero, et al.
The Oncologist
|
June 30, 2021
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial
Enrique Grande, Cristina Rodriguez-Antona, Carlos López, et al.
American Journal of Cancer Research
|
June 9, 2023
María Santos, Javier Lanillos, Eduardo Caleiras, et al.
International Journal of Cancer
|
June 1, 2023
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition
Juan M Roldán-Romero, Carlos Valdivia, Maria Santos, et al.
Cancers
|
November 13, 2020
Novel <i>DNMT3A</i> Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma
Sara Mellid, Javier Coloma, Bruna Calsina, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 4, 2020
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome
Juan María Roldan-Romero, María Santos, Javier Lanillos, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
NPJ Genomic Medicine
|
February 19, 2022
Clinical pharmacogenetic analysis in 5,001 individuals with diagnostic Exome Sequencing data
Javier Lanillos, Marta Carcajona, Paolo Maietta, et al.
European Urology
|
June 10, 2022
Interrogating the Significance of PARP1 Expression and PBRM1 Mutation as Biomarkers for Predicting the Response to Atezolizumab plus Bevacizumab or to Sunitinib in Patients with Clear Cell Renal Cell Carcinoma
Javier Lanillos, María Santos, Carlos Valdivia, et al.
Orphanet Journal of Rare Diseases
|
March 1, 2022
Considerations on diagnosis and surveillance measures of PTEN hamartoma tumor syndrome: clinical and genetic study in a series of Spanish patients
Laura Pena-Couso, María Ercibengoa, Fátima Mercadillo, et al.
Journal of Clinical Medicine
|
July 8, 2020
A Novel Approach for the Identification of Pharmacogenetic Variants in <i>MT-RNR1</i> through Next-Generation Sequencing Off-Target Data
Javier Lanillos, María Santos, Marta Carcajona, et al.
Genetics in Medicine : Official Journal of the American College of Medical Genetics
|
January 14, 2021
Prevalence of pathogenic germline variants in patients with metastatic renal cell carcinoma
María Santos, Javier Lanillos, Juan María Roldan-Romero, et al.
The Oncologist
|
June 30, 2021
Sunitinib and Evofosfamide (TH-302) in Systemic Treatment-Naïve Patients with Grade 1/2 Metastatic Pancreatic Neuroendocrine Tumors: The GETNE-1408 Trial
Enrique Grande, Cristina Rodriguez-Antona, Carlos López, et al.
American Journal of Cancer Research
|
June 9, 2023
María Santos, Javier Lanillos, Eduardo Caleiras, et al.
International Journal of Cancer
|
June 1, 2023
Deubiquitinase USP9X loss sensitizes renal cancer cells to mTOR inhibition
Juan M Roldán-Romero, Carlos Valdivia, Maria Santos, et al.
Cancers
|
November 13, 2020
Novel <i>DNMT3A</i> Germline Variant in a Patient with Multiple Paragangliomas and Papillary Thyroid Carcinoma
Sara Mellid, Javier Coloma, Bruna Calsina, et al.
Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc
|
July 4, 2020
Molecular characterization of chromophobe renal cell carcinoma reveals mTOR pathway alterations in patients with poor outcome
Juan María Roldan-Romero, María Santos, Javier Lanillos, et al.
Page
of 2